Dudediligence.

CRISPR Therapeutics AG

CRSPNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$11.1M

7 notices · 188,751 sh

Oct 2025 to Oct 2026

Reported ·

$16.9M

26 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

10 of 26 reported sales carry the 10b5-1 box. Together they are 0.30% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-22: JAMES KASINGER, Form 1442026-09-17: ALI BEHBAHANI, Form 1442026-01-22: Samarth Kulkarni, Form 1442026-01-22: RAJU PRASAD, Form 1442026-01-20: Samarth Kulkarni, Form 1442026-01-06: RAJU PRASAD, Form 1442025-12-22: RAJU PRASAD, Form 1442025-10-14: KASINGER JAMES R., sold2025-10-14: Kulkarni Samarth, sold2025-10-17: Kulkarni Samarth, sold2025-12-22: Prasad Raju, sold2026-01-06: Prasad Raju, sold2026-01-20: Kulkarni Samarth, sold2026-01-22: Prasad Raju, sold2026-02-19: KASINGER JAMES R., sold2026-02-19: Kulkarni Samarth, sold2026-03-11: Kulkarni Samarth, sold2026-03-11: KASINGER JAMES R., sold2026-03-16: Kulkarni Samarth, sold2026-03-16: KASINGER JAMES R., sold2026-03-16: Prasad Raju, sold2026-03-16: Patel Naimish, sold2026-03-23: Prasad Raju, sold2026-03-23: Kulkarni Samarth, sold2026-03-23: KASINGER JAMES R., sold2026-05-29: Patel Naimish, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-22JAMES KASINGER, General Counsel and Secretary$626,460
10,400 shplan 2026-05-06Form 4s on file end Jun 23144 ↗
2026-09-17ALI BEHBAHANI, Director$780,935
13,679 shno plan dateForm 4s on file end Jun 23144 ↗
2026-01-22Samarth Kulkarni, Chief Executive Officer$3,648,600
60,000 shplan 2025-08-27144 ↗
Form 4, 2026-02-20: sold 6,967 at $52.58 Form 4 ↗
2026-01-22RAJU PRASAD, Chief Financial Officer$2,105,070
34,972 shplan 2025-08-18144 ↗
Form 4, 2026-01-26: sold 34,972 at $60.19 Form 4 ↗
2026-01-20Samarth Kulkarni, Chief Executive Officer$1,578,300
30,000 shplan 2025-08-27144 ↗
Form 4, 2026-01-22: sold 90,000 at $57.40 Form 4 ↗
2026-01-06RAJU PRASAD, Chief Financial Officer$1,786,636
29,700 shplan 2025-08-18144 ↗
Form 4, 2026-01-08: sold 29,700 at $60.16 Form 4 ↗
2025-12-22RAJU PRASAD, Chief Financial Officer$559,548
10,000 shplan 2025-08-18144 ↗
Form 4, 2025-12-23: sold 10,000 at $55.95 Form 4 ↗